Roflumilast
|
|
appearance as argument number 1 |
(documentation Roflumilast EnglishLanguage "Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD) [from Wikipedia]") | Medicine.kif 3925-3930 | |
(sideEffect Roflumilast Diarrhea) | Medicine.kif 3935-3935 | Diarrhea is a side effect of taking roflumilast |
(sideEffect Roflumilast Headache) | Medicine.kif 3934-3934 | Headache is a side effect of taking roflumilast |
(sideEffect Roflumilast Nausea) | Medicine.kif 3933-3933 | Nausea is a side effect of taking roflumilast |
(subclass Roflumilast Antiinflammatory) | Medicine.kif 3924-3924 | Roflumilast is a subclass of Antiinflammatory |
appearance as argument number 2 |
(diseaseMedicine ChronicObstructivePulmonaryDisease Roflumilast Ingesting) | Medicine.kif 3932-3932 | COPD is disease treatment roflumilast for ingesting |
(subclass Daxas Roflumilast) | Medicine.kif 3937-3937 | Daxas is a subclass of roflumilast |
(termFormat EnglishLanguage Roflumilast "roflumilast") | Medicine.kif 3931-3931 |